The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. The effect of NG-nitro-L-arginine methyl ester and L-arginine

Medical Science Monitor

Volumn 12, Issue 1, 2006, Pages

  Boban Blagaic, Alenka ^a   Blagaic, Vladimir ^b   Romic, Zeljko ^a   Jelovac, Nikola ^a   Dodig, Goran ^a   Rucman, Rudolf ^a   Petek, Marijan ^a   Turkovic, Branko ^a   Seiwerth, Sven ^a   Sikiric, Predrag ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b NONE

Author keywords

Acute alcohol intoxication; Chronic alcohol consumption; Interaction; NO related agents; Stable gastric pentadecapeptide BPC 157; Withdrawal

Indexed keywords

ALCOHOL; ARGININE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYL ALANYLGLYCYLLEUCYLVALINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; N(G) NITROARGININE METHYL ESTER; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ALCOHOL INTOXICATION; ALCOHOL WITHDRAWAL; ANESTHESIA (SENSORY DYSFUNCTION); ANIMAL EXPERIMENT; AREFLEXIA; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRINKING BEHAVIOR; HYPOTHERMIA; MORTALITY; MOUSE; NONHUMAN; RIGHTING REFLEX; SYMPTOM; WITHDRAWAL SEIZURE;

ALCOHOL DRINKING; ANIMALS; ANTI-ULCER AGENTS; ARGININE; BEHAVIOR; ENZYME INHIBITORS; ETHANOL; HUMANS; MALE; MICE; NG-NITROARGININE METHYL ESTER; PEPTIDE FRAGMENTS; PROTEINS;

EID: 30944442647     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Boban Blagaic A, Blagaic V, Romic Z, Sikiric P: The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. European J Pharmacol, 2004; 499: 285-90
2. Sikiric P, Seiwerth S, Grabarevic Z et al: The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesion induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promoters and gut peptides. Life Sci, 1994; 54: 63-68
3. Sikiric P, Seiwerth S, Grabarevic Z et al: The influence of a novel pentadecapeptide BPC 157 on NG-nitro-L-arginine methylester and L-arginine effect on stomach mucosal integrity and blood pressure. European J Pharmacol, 1997; 332: 23-33
4. Sikiric P, Seiwerth S, Deskovic S et al: New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin. European J Pharmacol, 1999; 364: 23-31
5. Veljaca M, Krnic Z, Brajsa K et al: The development of PL 14736 for treatment of inflammatory bowel disease. IUPHAR-GI Section Symposium, Honolulu, Hawaii, 2002; 13-15, O-32
6. Jelovac N, Sikiric P, Rucman R et al: A novel pentadecapeptide, BPC 157, blocks the produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine. Biol Psychiatry, 1998; 43: 511-19
7. Jelovac N, Sikiric P, Rucman R et al: Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats. European J Pharmacol, 1999; 379: 19-31
8. Sikiric P, Marovic A, Matoz W et al: A behavioral study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropropyridine. J Physiol (Paris), 1999; 93: 505-12
9. Sikiric P, Separovic J, Buljat G et al: The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants. J Physiol (Paris), 2000; 94: 99-104
10. Sikiric P, Jelovac N, Gjeldum A et al: Anxiolytic effect of BPC 157, a gastric pentadecapeptide: shock probe/burying test and light/dark test. Acta Pharmacol Sin, 2001; 22: 225-30
11. Sikiric P, Jelovac N, Gjeldum A et al: Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances. Acta Pharmacol Sin, 2002; 23: 412-22
12. Prkacin I, Aralica G, Perovic D et al: Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats. J Physiol (Paris), 2001; 95: 295-301
13. Prkacin I, Separovic J, Aralica G et al: Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine. J Physiol (Paris), 2001; 95: 315-24
14. Prkacin I, Staresinic M, Suknaic S et al: Reduction of Doppler shift of otherwise increased blood flow velocity in v. cava inferior and v. portae of chronically alcohol drinking portal hypertensive rats by gastric pentadecapeptide BPC 157 (PL-10). Gastroenterology, 2002; 122: 353
15. Sikiric P, Seiwerth S, Grabarevic Z et al: Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatin. Life Sci, 1993; 53: PL291-96
16. Adams ML, Cicero TJ: Alcohol intoxication and withdrawal: The role of nitric oxide. Alcohol, 1998; 16: 153-58
17. Cohen C, Perrault G, Sanger DJ: Evidence for the involvement of dopamine receptors in ethanol-induced hyperactivity in mice. Neuropharmacology, 1997; 36: 1099-108
18. Malinowska B, Napiorkowska-Pawlak D, Pawlak R et al: Ifenprodil influences changes in mouse behavior related to acute and chronic ethanol administration. European J Pharmacol, 1999; 377: 13-19
19. Tracy HA Jr, Wayner MJ: Losartan blocks diazepam and ethanol effects on air righting. Alcohol, 1998; 16: 93-99
20. Daniell LC: Alteration of general anesthetic potency by agonists and antagonists of the polyamine binding site of the polyamine binding site of the N-methly-D-aspartate receptor. J Pharmacol Exp Ther, 1992; 261: 304-10
21. Zink BJ, Schultz CH, Stern SA et al: Effects of ethanol and naltrexone in a model of traumatic brain injury with hemorrhagic shock. Alcohol Clin Exp Res, 2001; 25: 916-23
22. Dar MS: Involvement of kappa-opioids in the mouse cerebellar adenosinergic modulation of ethanol-induced motor incoordination. Alcohol Clin Exp Res, 1998; 22: 444-54
23. Popova NK, Ivanova EA: 5-HT(1A) receptor antagonist p-MPPI attenuates acute ethanol effects in mice and rats. Neurosci Lett, 2002; 322: 1-4
24. Costall B, Jones BJ, Kelly ME et al: Ondansetron inhibits a behavioral consequence of withdrawing from drugs of abuse. Pharmacol Biochem Behav, 1990; 36: 339-44
25. Mehta AK, Ticku MK: Ethanol- and diazepam-withdrawal hyper locomotion is not due to 5-HT3 receptor stimulation. Pharmacol Biochem Behav, 1993; 45: 755-57
26. Grant KA, Hellevuo K, Tabakoff B: The 5-HT3 antagonist MDL 72222 exacerbates ethanol withdrawal seizures in mice. Alcohol Clin Exp Res, 1994; 18: 410-14
27. Smith JW, Little HJ: Differential effects of a dihydropyridine calcium channel antagonist on the components of ethanol tolerance. Brain Res, 2000; 863: 9-19
28. Wallis CJ, Rezazadeh SM, Lal H: GM1 ganglioside reduces ethanol intoxication and the development of ethanol dependence. Alcohol, 1995; 12: 573-80
29. French TA, Masserano JM, Weiner N: In. uence of thyrotropin-releasing hormone and catecholaminergic interactions on CNS ethanol sensitivity. Alcohol Clin Exp Res, 1993; 17: 99-106
30. Uzbay IT, Yesilyurt O, Celik T et al: Effects of agmatine on ethanol withdrawal syndrome in rats. Behav Brain Res, 2000; 107: 153-59
31. Zou JY, Martinez DB, Neafsey EJ, Collins MA: Binge ethanol-induced brain damage in rats: effect of inhibitors of nitric oxide synthase. Alcohol Clin Exp Res, 1996; 20: 1406-11
32. Adams ML, Sewing BN, Chen J et al: Nitric oxide-related agents alter alcohol withdrawal in male rats. Alcohol Clin Exp Res, 1995; 19: 195-99
33. Uzbay IT: L-NAME precipitates catatonia during ethanol withdrawal in rats. Behav Brain Res, 2001; 119: 71-76
34. Uzbay IT, Erden BF: Attenuation of ethanol withdrawal signs by high doses of L-arginine in rats. Alcohol Alcohol, 2003; 38: 213-18
35. Świa̧tkowski M, Budzyński J, Kłopocka M et al: Parameters of the functional and morphological status of the upper digestive tract in alcoholdependent male patients with depression and alexithymia in the context of autonomic nervous system activity and nitric oxide plasma level. Med Sci Monit, 2004; 10(2): CR68-CR74
36. Whittle BJR, Boughton-Smith NK, Moncada S: Biosynthesis and role of the endothelium-derived vasodilator, nitric oxide in gastric mucosa. Ann. NY Acad Sci, 1992; 664: 126-39
37. Lovric-Bencic M, Sikiric P, Separovic J et al: Doxorubicine congestive heart failure-increased big-endothelin 1 plasma concentration. Reversal by amlodipine, losartan and gastric pentadecapeptide BPC 157 in rat and mouse. J Pharmacol Sci, 2004; 95: 19-26
38. Grogan JR, Kochar MS: Alcohol and hypertension. Arch Fam Med, 1994; 3: 150-54
39. Lavallee M, Takamura M, Parent R, Thorin E. Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail Rev, 2001; 6: 265-76
40. Tohoyama Y, Sikiric P, Diksic M: Effects of antiulcer pentadecapeptide BPC157 on regional serotonin synthesis in rat brain: α-methyl-L-tryptophan autoradiographic measurements. Life Sci, 2004; 76: 345-57
41. Staresinic M, Sebecic B, Jadrijevic S et al: Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res, 2003; 21: 976-83
42. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev, 1991; 43: 109-42
43. Lopez-Belmonte J, Whittle BJR, Moncada S: The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol, 1993; 108: 73-80
44. Vapaatalo H, Mervaala E: Clinically important factors influencing endothelial function. Med Sci Monit, 2001; 7(5): 1075-85
45. Fadda F, Rossetti ZI: Chronic ethanol consumption: From neuroadaptation to neurodegeneration. Progress in Neurobiology, 1998; 56: 385-431
46. Ritzmann RF, Tabakoff B: Body temperature in mice: A quantitative measure of alcohol tolerance and physical dependence. J Pharmacol Exp Therap, 1976; 199: 158-70
47. Putzke J, De Beun R, Schreiber R et al: Long-term alcohol self-administration and alcohol withdrawal differentially modulate microtubule-associated protein 2 (MAP2) gene expression in the rat brain. Mol Brain Res, 1998; 62: 196-205
48. rd (Berl), 1979; 60: 195-201
49. Veljaca M, Chan K, Guglietta A: Digestion of h-EGF, h-TGF alpha and BPC-15 in human gastric juice. Gastroenterology, 1995; 108: 761